Study of FG-4592 in Subjects With End-Stage Renal Disease Receiving Maintenance Hemodialysis



Status:Archived
Conditions:Renal Impairment / Chronic Kidney Disease, Anemia
Therapuetic Areas:Hematology, Nephrology / Urology
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:March 2010
End Date:June 2011

Use our guide to learn which trials are right for you!


The purpose of this study is to evaluate the safety of different doses of FG-4592 given to
subjects with End Stage Renal Disease on maintenance hemodialysis



We found this trial at
9
sites
Albany, New York
?
mi
from
Albany, NY
Click here to add this to my saved trials
Atlanta, Georgia
?
mi
from
Atlanta, GA
Click here to add this to my saved trials
Austin, Texas
?
mi
from
Austin, TX
Click here to add this to my saved trials
?
mi
from
Lima, OH
Click here to add this to my saved trials
Metairie, Louisiana
?
mi
from
Metairie, LA
Click here to add this to my saved trials
Nashville, Tennessee
?
mi
from
Nashville, TN
Click here to add this to my saved trials
Peoria, Arizona
?
mi
from
Peoria, AZ
Click here to add this to my saved trials
Richmond, Virginia
?
mi
from
Richmond, VA
Click here to add this to my saved trials
Santa Clara, California 95051
?
mi
from
Santa Clara, CA
Click here to add this to my saved trials